Activation of MEK1/2/Nrf-2 Signaling Pathway by Epstein-Barr Virus-Latent Membrane Protein 1 Enhances Autophagy and Cisplatin Resistance in T-Cell Lymphoma

Epstein-Barr virus-latent membrane protein 1 (EBV-LMP1) was associated with lymphoma, but its specific mechanism is still controversial. The study is aimed at studying the regulation of lymphoma resistance by EBV-LMP1 through the MEK1/2/Nrf-2 signaling pathway. First, LMP1 was knocked down in EBV-po...

Full description

Saved in:
Bibliographic Details
Main Authors: Xintao Jia, Qiuyu He, Mei Zeng, Yuhua Chen, Yan Liu
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Analytical Cellular Pathology
Online Access:http://dx.doi.org/10.1155/2021/6668947
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832565236562919424
author Xintao Jia
Qiuyu He
Mei Zeng
Yuhua Chen
Yan Liu
author_facet Xintao Jia
Qiuyu He
Mei Zeng
Yuhua Chen
Yan Liu
author_sort Xintao Jia
collection DOAJ
description Epstein-Barr virus-latent membrane protein 1 (EBV-LMP1) was associated with lymphoma, but its specific mechanism is still controversial. The study is aimed at studying the regulation of lymphoma resistance by EBV-LMP1 through the MEK1/2/Nrf-2 signaling pathway. First, LMP1 was knocked down in EBV-positive SNK-6 cells and overexpressed in EBV-negative KHYG-1 cells. First, we found that overexpression of LMP1 significantly promoted the resistance of KHYG-1 cells to cisplatin (DDP), which was related to increased autophagy in the cells. In contrast, knockdown of LMP1 expression in SNK-6 cells promoted cellular sensitivity to DDP and reduced the autophagy of cells after DDP treatment. Moreover, specific inhibition of autophagy in KHYG-1 cells significantly attenuated the resistance to DDP caused by overexpression of LMP1, but treatment with rapamycin in SNK-6 cells significantly promoted the autophagy in the cells. Subsequently, overexpression of LMP1 promoted the activation of the MEK1/2-Nrf2 pathway in KYHG-1 cells, whereas knockdown of LMP1 in SNK-6 cells inhibited the activation of the MEK1/2-Nrf2 pathway. Inhibition of MEK1/2/Nrf-2 blocked the promoting effects of LMP1 on lymphoma cell resistance. In conclusion, EBV-LMP1 promotes cell autophagy after DDP treatment by activating the MEK1/2/Nrf-2 signaling pathway in lymphoma cells, thus, enhancing the resistance of lymphoma cells to DDP.
format Article
id doaj-art-62affd38020044668fc1e9fb6e27bf7b
institution Kabale University
issn 2210-7177
2210-7185
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Analytical Cellular Pathology
spelling doaj-art-62affd38020044668fc1e9fb6e27bf7b2025-02-03T01:08:52ZengWileyAnalytical Cellular Pathology2210-71772210-71852021-01-01202110.1155/2021/66689476668947Activation of MEK1/2/Nrf-2 Signaling Pathway by Epstein-Barr Virus-Latent Membrane Protein 1 Enhances Autophagy and Cisplatin Resistance in T-Cell LymphomaXintao Jia0Qiuyu He1Mei Zeng2Yuhua Chen3Yan Liu4Department of Pathology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Sciences, Xiangyang, 441021 Hubei, ChinaDepartment of Pathology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Sciences, Xiangyang, 441021 Hubei, ChinaDepartment of Pathology Teaching and Research Section, Xiangyang Polytechnic, Xiangyang, 441050 Hubei, ChinaDepartment of Pathology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Sciences, Xiangyang, 441021 Hubei, ChinaDepartment of Pathology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Sciences, Xiangyang, 441021 Hubei, ChinaEpstein-Barr virus-latent membrane protein 1 (EBV-LMP1) was associated with lymphoma, but its specific mechanism is still controversial. The study is aimed at studying the regulation of lymphoma resistance by EBV-LMP1 through the MEK1/2/Nrf-2 signaling pathway. First, LMP1 was knocked down in EBV-positive SNK-6 cells and overexpressed in EBV-negative KHYG-1 cells. First, we found that overexpression of LMP1 significantly promoted the resistance of KHYG-1 cells to cisplatin (DDP), which was related to increased autophagy in the cells. In contrast, knockdown of LMP1 expression in SNK-6 cells promoted cellular sensitivity to DDP and reduced the autophagy of cells after DDP treatment. Moreover, specific inhibition of autophagy in KHYG-1 cells significantly attenuated the resistance to DDP caused by overexpression of LMP1, but treatment with rapamycin in SNK-6 cells significantly promoted the autophagy in the cells. Subsequently, overexpression of LMP1 promoted the activation of the MEK1/2-Nrf2 pathway in KYHG-1 cells, whereas knockdown of LMP1 in SNK-6 cells inhibited the activation of the MEK1/2-Nrf2 pathway. Inhibition of MEK1/2/Nrf-2 blocked the promoting effects of LMP1 on lymphoma cell resistance. In conclusion, EBV-LMP1 promotes cell autophagy after DDP treatment by activating the MEK1/2/Nrf-2 signaling pathway in lymphoma cells, thus, enhancing the resistance of lymphoma cells to DDP.http://dx.doi.org/10.1155/2021/6668947
spellingShingle Xintao Jia
Qiuyu He
Mei Zeng
Yuhua Chen
Yan Liu
Activation of MEK1/2/Nrf-2 Signaling Pathway by Epstein-Barr Virus-Latent Membrane Protein 1 Enhances Autophagy and Cisplatin Resistance in T-Cell Lymphoma
Analytical Cellular Pathology
title Activation of MEK1/2/Nrf-2 Signaling Pathway by Epstein-Barr Virus-Latent Membrane Protein 1 Enhances Autophagy and Cisplatin Resistance in T-Cell Lymphoma
title_full Activation of MEK1/2/Nrf-2 Signaling Pathway by Epstein-Barr Virus-Latent Membrane Protein 1 Enhances Autophagy and Cisplatin Resistance in T-Cell Lymphoma
title_fullStr Activation of MEK1/2/Nrf-2 Signaling Pathway by Epstein-Barr Virus-Latent Membrane Protein 1 Enhances Autophagy and Cisplatin Resistance in T-Cell Lymphoma
title_full_unstemmed Activation of MEK1/2/Nrf-2 Signaling Pathway by Epstein-Barr Virus-Latent Membrane Protein 1 Enhances Autophagy and Cisplatin Resistance in T-Cell Lymphoma
title_short Activation of MEK1/2/Nrf-2 Signaling Pathway by Epstein-Barr Virus-Latent Membrane Protein 1 Enhances Autophagy and Cisplatin Resistance in T-Cell Lymphoma
title_sort activation of mek1 2 nrf 2 signaling pathway by epstein barr virus latent membrane protein 1 enhances autophagy and cisplatin resistance in t cell lymphoma
url http://dx.doi.org/10.1155/2021/6668947
work_keys_str_mv AT xintaojia activationofmek12nrf2signalingpathwaybyepsteinbarrviruslatentmembraneprotein1enhancesautophagyandcisplatinresistanceintcelllymphoma
AT qiuyuhe activationofmek12nrf2signalingpathwaybyepsteinbarrviruslatentmembraneprotein1enhancesautophagyandcisplatinresistanceintcelllymphoma
AT meizeng activationofmek12nrf2signalingpathwaybyepsteinbarrviruslatentmembraneprotein1enhancesautophagyandcisplatinresistanceintcelllymphoma
AT yuhuachen activationofmek12nrf2signalingpathwaybyepsteinbarrviruslatentmembraneprotein1enhancesautophagyandcisplatinresistanceintcelllymphoma
AT yanliu activationofmek12nrf2signalingpathwaybyepsteinbarrviruslatentmembraneprotein1enhancesautophagyandcisplatinresistanceintcelllymphoma